Carson Wealth (CWM LLC)’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12	Closed	–	–	4239
2022 Q1	$0	Hold	12	–	–	﹤0.01%	4021
2021 Q4	$0	Buy	+12	New	+$49	﹤0.01%	3714

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Carson Wealth (CWM LLC)'s KLDO Position: Q2 2022 in Review

Carson Wealth (CWM LLC) sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 12 shares.

Carson Wealth (CWM LLC) first reported a position in KLDO in Q4 2021 and held it in 2 quarters. The position peaked at $0 in Q1 2022. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

Carson Wealth (CWM LLC) reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Carson Wealth (CWM LLC) sold 12 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022.
Carson Wealth (CWM LLC) first reported a position in Kaleido Biosciences, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
Carson Wealth (CWM LLC)'s Kaleido Biosciences, Inc. Common Stock position peaked at $0 in Q1 2022.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2022, filed 28 Jul 2022.